Related Experiment Video
Updated: Mar 30, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Acremonium Pneumonia: Case Report and Literature Review
Atefeh Fakharian1, Atosa Dorudinia2, Ilad Alavi Darazam1
1Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Acremonium spp. cause human superficial infections including mycetoma, onychomycosis and keratitis. There are a few reports of systemic involvement in immunocompromised patients. However, isolated pulmonary infection in otherwise healthy hosts has never been reported in the literature. Herein, we report a 59 year-old diabetic man with non-resolving pneumonia due to Acremonium spp. and provide a consensus review of the published clinical cases of systemic and respiratory tract infections.
Insights
Acremonium species rarely cause lung infections in healthy individuals. This report details a unique case of non-resolving pneumonia caused by Acremonium in a diabetic patient, highlighting rare pulmonary infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Acremonium species are known to cause superficial human infections like mycetoma, onychomycosis, and keratitis.
- Systemic infections with Acremonium are infrequently reported, primarily in immunocompromised individuals.
- Isolated pulmonary infections in immunocompetent hosts are exceptionally rare in existing literature.
Observation:
- A 59-year-old diabetic male presented with persistent, non-resolving pneumonia.
- Diagnostic investigations confirmed the causative agent to be Acremonium species.
- This presentation is unusual given the patient's otherwise healthy status.
Findings:
- This case represents the first documented instance of isolated pulmonary infection by Acremonium species in an immunocompetent host.
- A comprehensive review of published clinical cases of Acremonium systemic and respiratory tract infections was conducted.
- The findings underscore the potential for Acremonium to cause severe respiratory disease even in non-immunocompromised individuals.
Implications:
- This case expands the known spectrum of clinical manifestations for Acremonium infections.
- It emphasizes the importance of considering less common fungal pathogens in the differential diagnosis of persistent pneumonia.
- Further research is warranted to understand the pathogenesis and treatment strategies for pulmonary Acremonium infections.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

